NORTH AMERICA CLINICAL NUTRITION MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA CLINICAL NUTRITION MARKET FORECAST 2019-2028

NORTH AMERICA CLINICAL NUTRITION MARKET FORECAST 2019-2028

The North America clinical nutrition market is estimated to project a CAGR of 5.27% during the forecast period, 2019-2028. The region houses an increasing geriatric population and a rising number of people with chronic diseases like diabetes and cancer. These factors are assessed to impact the market growth of the region. The United States and Canada are evaluated for the North America clinical nutrition market growth analysis. The healthcare expenditure in the US has projected an upward graph over the years.

NORTH AMERICA CLINICAL NUTRITION MARKET FORECAST 2019-2028

North America Clinical Nutrition Market by Route of Administration (Oral, Enteral, Parenteral) by Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, Other Applications) by End-user (Pediatric, Geriatric, Adults) and by Geography.

Request free sample

The North America clinical nutrition market is estimated to project a CAGR of 5.27% during the forecast period, 2019-2028. The region houses an increasing geriatric population and a rising number of people with chronic diseases like diabetes and cancer. These factors are assessed to impact the market growth of the region.
north america clinical nutrition market

To know more about this report, request a free sample copy

The United States and Canada are evaluated for the North America clinical nutrition market growth analysis. The healthcare expenditure in the US has projected an upward graph over the years. The country spends a considerable part of its GDP on healthcare. Also, as per the PRB, the population aged above 65 in the US was almost 52 million in 2018. The US population, with a sedentary lifestyle and unhealthy diet choices, is expectant of a rise in metabolic disorders like diabetes and hypercholesterolemia. The market growth is also set to be impacted by stringent regulations, with regard to product safety, efficacy claims, and manufacturing. Consumer confidence in terms of product safety is also analyzed to be beneficial for market growth. The American Cancer Society estimates that the number of colon cancer and rectal cancers is set to surge in 2020. This will further augment the growth of the market, since the patients are more often in need of essential nutrients. Further, in terms of product development, Abbott Nutrition launched a nutrition drink in April 2017, for better recovery of patients post-surgery.

Exela Pharma Sciences is a specialty pharmaceutical company that manufactures, develops, and markets generic and proprietary, sterile injectable products. The company’s products enhance the patine experience through ease of burden in administration, faster drug preparation, reduced drug waste, etc. Exela focuses on efficient delivery with regard to reliability, quality, and affordability. The company is based in North Carolina, the US.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • INCREASING PREVALENCE OF CHRONIC DISEASES AND LIFESTYLE ASSOCIATED DISEASE
      • RISE IN ELDERLY POPULATION
      • HIGH OCCURRENCE OF MALNUTRITION AMONG HOSPITALIZED PATIENTS
    •    KEY RESTRAINTS
      • LACK OF AWARENESS FOR CLINICAL NUTRITION
      • COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING
      • STRINGENT REGULATIONS
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY ROUTE OF ADMINISTRATION
    • ORAL
    • ENTERAL
    • PARENTERAL
  3. MARKET BY APPLICATION
    • CANCER
    • NEUROLOGICAL DISEASES
    • GASTROINTESTINAL DISORDERS
    • METABOLIC DISORDERS
    • OTHER APPLICATIONS
  4. MARKET BY END-USER
    • PEDIATRIC
    • GERIATRIC
    • ADULTS
  5. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPANY PROFILES
    • ABBOTT LABORATORIES
    • AMERICAN REGENT INC
    • BASF SE
    • BAXTER INTERNATIONAL INC
    • BRAUN
    • DANONE
    • EXELA PHARMA SCIENCES
    • GRIFOLS SA
    • LONZA LTD
    • MEIJI HOLDINGS CO LTD
    • NESTLE HEALTH SCIENCE
    • OTSUKA HOLDINGS CO LTD
    • RECKITT BENCKISER GROUP PLC
    • SANOFI
    • SICHUAN KELUN PHARMACEUTICAL CO LTD

TABLE LIST

TABLE 1: MARKET SNAPSHOT – CLINICAL NUTRITION

TABLE 2: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 4: NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA CLINICAL NUTRITION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: NORTH AMERICA CLINICAL NUTRITION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: MAJOR CATEGORIES OF NORTH AMERICA HEALTH SPENDING, 2017

FIGURE 2: COMPLICATIONS OF ENTERAL FEEDING

FIGURE 3: PORTER’S FIVE FORCE ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: KEY INVESTMENT INSIGHTS

FIGURE 7: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, IN 2019

FIGURE 8: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, IN 2019

FIGURE 12: NORTH AMERICA CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)

FIGURE 15: NORTH AMERICA CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA CLINICAL NUTRITION MARKET, BY END-USER, IN 2019

FIGURE 18: NORTH AMERICA CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)

FIGURE 20: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)

FIGURE 21: NORTH AMERICA CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 22: THE UNITED STATES CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 23: CANADA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY ROUTE OF ADMINISTRATION
    • ORAL
    • ENTERAL
    • PARENTERAL
  2. MARKET BY APPLICATION
    • CANCER
    • NEUROLOGICAL DISEASES
    • GASTROINTESTINAL DISORDERS
    • METABOLIC DISORDERS
    • OTHER APPLICATIONS
  3. MARKET BY END-USER
    • PEDIATRIC
    • GERIATRIC
    • ADULTS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now